ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $179.51 million. The enterprise value is $384.74 million.
Important Dates
The next confirmed earnings date is Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 99.18 million shares outstanding. The number of shares has increased by 18.91% in one year.
| Current Share Class | 99.18M |
| Shares Outstanding | 99.18M |
| Shares Change (YoY) | +18.91% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 6.42% |
| Owned by Institutions (%) | 29.89% |
| Float | 73.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.81 |
| Forward PS | 1.66 |
| PB Ratio | -0.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.46
| Current Ratio | 4.46 |
| Quick Ratio | 3.92 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -27.02% |
| Return on Invested Capital (ROIC) | -34.85% |
| Return on Capital Employed (ROCE) | -58.44% |
| Revenue Per Employee | $286,102 |
| Profits Per Employee | -$565,442 |
| Employee Count | 265 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 6.89 |
Taxes
In the past 12 months, ADCT has paid $168,000 in taxes.
| Income Tax | 168,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.04% in the last 52 weeks. The beta is 1.55, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | -57.04% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 2.22 |
| Relative Strength Index (RSI) | 71.52 |
| Average Volume (20 Days) | 359,094 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ADCT had revenue of $75.82 million and -$149.84 million in losses. Loss per share was -$1.45.
| Revenue | 75.82M |
| Gross Profit | -39.32M |
| Operating Income | -125.51M |
| Pretax Income | -170.29M |
| Net Income | -149.84M |
| EBITDA | -124.17M |
| EBIT | -125.51M |
| Loss Per Share | -$1.45 |
Full Income StatementBalance Sheet
The company has $194.70 million in cash and $448.52 million in debt, giving a net cash position of -$253.82 million or -$2.56 per share.
| Cash & Cash Equivalents | 194.70M |
| Total Debt | 448.52M |
| Net Cash | -253.82M |
| Net Cash Per Share | -$2.56 |
| Equity (Book Value) | -238.22M |
| Book Value Per Share | -2.22 |
| Working Capital | 200.20M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | -124.70M |
| FCF Per Share | -$1.26 |
Full Cash Flow StatementMargins
Gross margin is -51.86%, with operating and profit margins of -165.54% and -197.64%.
| Gross Margin | -51.86% |
| Operating Margin | -165.54% |
| Pretax Margin | -197.41% |
| Profit Margin | -197.64% |
| EBITDA Margin | -163.77% |
| EBIT Margin | -165.54% |
| FCF Margin | n/a |